Better Therapeutics Inc. (BTTX)
0.00
null (null%)
At close: Jan 16, 2025, 3:00 PM
0.01
7300.00%
Pre-market Jun 20, 2024, 09:30 AM EDT
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY22 | FY21 | FY20 | FY19 |
| Revenue | n/a | n/a | 8.00K | 18.00K |
| Cost of Revenue | 2.73M | 1.62M | 682.00K | 898.00K |
| Gross Profit | -2.73M | -1.62M | -674.00K | -880.00K |
| Operating Income | -38.26M | -30.56M | -6.32M | -5.77M |
| Interest Income | 1.49K | 185.00 | 100.00 | 11.00 |
| Pretax Income | -39.75M | -40.49M | -6.23M | -5.78M |
| Net Income | -39.76M | -40.34M | -6.39M | -5.79M |
| Selling & General & Admin | 21.82M | 11.12M | 2.67M | 2.60M |
| Research & Development | 16.44M | 19.44M | 2.98M | 2.29M |
| Other Expenses | n/a | n/a | n/a | n/a |
| Operating Expenses | 38.26M | 30.56M | 5.65M | 4.89M |
| Interest Expense | 1.49M | 185.00K | 100.00K | 11.00K |
| Selling & Marketing Expenses | 6.98M | 2.34M | 216.00K | 406.00K |
| Cost & Expenses | 38.26M | 30.56M | 6.33M | 5.79M |
| Income Tax | 7.00K | -153.00K | 153.00K | 11.00K |
| Shares Outstanding (Basic) | 23.56M | 23.60M | 7.56M | 23.60M |
| Shares Outstanding (Diluted) | 23.56M | 23.60M | 7.56M | 23.60M |
| EPS (Basic) | -1.69 | -1.71 | -0.85 | -0.25 |
| EPS (Diluted) | -1.69 | -1.71 | -0.85 | -0.25 |
| EBITDA | -38.26M | -30.56M | -6.25M | -5.70M |
| Depreciation & Amortization | 2.73M | 1.62M | 75.00K | 72.00K |